$23.99
4.80% day before yesterday
NYSE, Nov 14, 10:00 pm CET

Zepp Health ADR A ADR Stock price

$23.99
-27.51 53.42% 1M
+21.24 772.36% 6M
+21.39 822.69% YTD
+20.60 607.67% 1Y
+19.11 391.60% 3Y
-27.74 53.62% 5Y
-19.53 44.88% 10Y
-19.53 44.88% 20Y
NYSE, Closing price Fri, Nov 14 2025
-1.21 4.80%

Key metrics

Basic
Market capitalization
$404.6m
Enterprise Value
$540.6m
Net debt
$136.0m
Cash
$56.0m
Shares outstanding
233.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
2.0 | 0.2
EV/Sales
2.7 | 0.3
EV/FCF
-
P/B
1.8
Dividends
DPS
$0.00
Yield 1Y | 5Y
0.0% | 0.0%
Growth 1Y | 5Y
- | -
Payout 1Y | 3Y
0.0% | -67.8%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$200.0m | $1.8b
EBITDA
- | $-161.3m
EBIT
$-55.7m | $-179.5m
Net Income
$-77.9m | $-204.6m
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
-18.9% | 890.1%
EBITDA
- | -281.9%
EBIT
-131.3% | -279.9%
Net Income
-192.9% | -170.2%
Free Cash Flow
-
Margin (TTM | estimate)
Gross
37.6%
EBITDA
- | -8.9%
EBIT
-27.9%
Net
-38.9% | -11.3%
Free Cash Flow
-
Financial Health
Equity Ratio
47.6%
Return on Equity
-30.1%
ROCE
-18.5%
ROIC
-17.0%
Debt/Equity
0.9
More
EPS
$-0.3
FCF per Share
-
Short interest
6.6%
Employees
765
Rev per Employee
$240.0k
Show more

Is Zepp Health ADR A ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,042 stocks worldwide.

Zepp Health ADR A ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Zepp Health ADR A ADR forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Zepp Health ADR A ADR forecast:

Buy
88%
Hold
13%

Financial data from Zepp Health ADR A ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
200 200
19% 19%
100%
- Direct Costs 125 125
21% 21%
62%
75 75
15% 15%
38%
- Selling and Administrative Expenses 75 75
13% 13%
37%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -56 -56
131% 131%
-28%
Net Profit -78 -78
193% 193%
-39%

In millions USD.

Don't miss a Thing! We will send you all news about Zepp Health ADR A ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Zepp Health ADR A ADR Stock News

Neutral
Seeking Alpha
12 days ago
Zepp Health Corporation ( ZEPP ) Q3 2025 Earnings Call November 4, 2025 8:30 PM EST Company Participants Grace Yujia Zhang - Director of Investor Relations Wang Huang - Founder, Chairman & CEO Leon Cheng Deng - Chief Financial Officer Conference Call Participants Siddharth Rajeev - Fundamental Research Corp. Dylan Chu Yuan Zhu Presentation Operator Hello, ladies and gentlemen. Thank you for sta...
Neutral
PRNewsWire
12 days ago
MILPITAS, Calif. , Nov. 4, 2025 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today announced its unaudited financial results for the third quarter of 2025.
Neutral
PRNewsWire
27 days ago
Earnings Call Scheduled for 8 : 3 0 p.m. ET  on  November 4 ,  2025 MILPITAS, Calif.
More Zepp Health ADR A ADR News

Company Profile

Zepp Health Corp. engages in the development, manufacture, and sale of smart wearable technology devices. It operates through Xiaomi Wearable Products, and Self-branded Products and Others segments. The Xiaomi Wearable Products segment comprises of sales of Xiaomi-branded products. The Self-branded Products and Others segment includes self-branded products. The company was founded by Huang Wang in December 2014 and is headquartered in Hefei, China.

Head office Cayman Islands
CEO Wang Huang
Employees 765
Founded 2013
Website www.huami.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today